stockrowAclaris Therapeutics, Inc. (ACRS) vs Apnimed, Inc. (APMD)
- Aclaris Therapeutics, Inc. ACRS 3.88 +7.48%
- Apnimed, Inc. APMD 15.08 +6.50%
Aclaris Therapeutics, Inc. and Apnimed, Inc. are both Biotechnology companies. Aclaris Therapeutics, Inc. and Apnimed, Inc. are of similar size ($589.5M and $559.5M). Aclaris Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Apnimed, Inc. trades at 0.8×. Apnimed, Inc. has the higher net margin (81.6% vs −1,244.1%) and the higher return on invested capital (0.00% vs −107.7%). Across the 15 metrics below, Apnimed, Inc. leads on 13 and Aclaris Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | ACRS | APMD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 94.53% | 68.51% |
| Operating margin | (1,413.97%) | 19.88% | 0.00% |
| Net margin | (1,244.09%) | 81.56% | 0.00% |
| Free cash flow margin | (1,176.61%) | (71.50%) | 0.00% |
| Return on equity | (55.51%) | 0.00% | (51.96%) |
| Return on assets | (40.66%) | 0.00% | (46.06%) |
| Return on invested capital | (107.72%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack